← Back to Clinical Trials
Recruiting NCT07468409

NCT07468409 ORYOM Robotic Surgical System in Cataract Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07468409
Status Recruiting
Phase
Sponsor ForSight Robotics Ltd
Condition Cataract
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-02-20
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
ORYOM™ Robotic Surgical System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-02-20 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective, open-label clinical study designed to evaluate the performance and safety of the ORYOM Robotic Surgical System during cataract surgery.

Eligibility Criteria

Main Inclusion Criteria: * Patient aged 55 to 80 years * Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol * Patients are scheduled to undergo cataract surgery * Clear intraocular media, other than cataract * Pupil dilate according to stand of care Main Exclusion Criteria: * Prior ocular surgery or trauma in the study eye * Polar cataract in the study eye * Zonular instability or significant anterior segment abnormalities * Active ocular infection or uveitis * Pseudoexfoliation (PXF) syndrome in either eye * ASA Physical Status Classification \> 3 * Participation in another clinical trial within 30 days

Contact & Investigator

Central Contact

Merav Gat, M.Sc., MBA

✉ merav.gat@forsightrobotics.com

📞 +972547800259

Frequently Asked Questions

Who can join the NCT07468409 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, up to 80 Years, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07468409 currently recruiting?

Yes, NCT07468409 is actively recruiting participants. Contact the research team at merav.gat@forsightrobotics.com for enrollment information.

Where is the NCT07468409 trial being conducted?

This trial is being conducted at Makati City, Philippines.

Who is sponsoring the NCT07468409 clinical trial?

NCT07468409 is sponsored by ForSight Robotics Ltd. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology